AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Xvivo Perfusion AB (publ)

$6.88 +$0.34 (+5.20%)
OTC · 02 Sep 2026 20:00 UTC
Previous Close
$7.4
Day Range
$6.88 - $6.88
Year Range
$4.25$8.18
Market Cap
866.87M
AVG Volume
553
Trailing/Forward PE
90.46/-
PEG ratio
1.23
Dividend Yield
-
Next Earnings Date
2026-10-22
Primary Exchange
Other OTCUS
Revenue (SEK) · TTM
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XVIPY Revenue (SEK) · TTM by quarter
PeriodRevenue (SEK) · TTM
26 Q2904.09M
26 Q1836.01M
25 Q4804.87M
25 Q3810.81M
25 Q2822.93M
25 Q1854.98M
24 Q4822.41M
24 Q3750.59M
24 Q2698.73M
24 Q1642.95M
Net Income (SEK) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XVIPY Net Income (SEK) · TTM by quarter
PeriodNet Income (SEK) · TTM
26 Q289.7M
26 Q174.49M
25 Q424.47M
25 Q329.84M
25 Q2111.38M
25 Q1137M
24 Q4172.18M
24 Q3204.27M
24 Q2120.74M
24 Q1100.43M
Operating Income (SEK) · TTM
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XVIPY Operating Income (SEK) · TTM by quarter
PeriodOperating Income (SEK) · TTM
26 Q2109.64M
26 Q194.02M
25 Q488.08M
25 Q367.18M
25 Q269.58M
25 Q195.93M
24 Q488.35M
24 Q347.73M
24 Q232.56M
24 Q12.94M
EBITDA (SEK) · TTM
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XVIPY EBITDA (SEK) · TTM by quarter
PeriodEBITDA (SEK) · TTM
26 Q2186.68M
26 Q1159.41M
25 Q4144.94M
25 Q3117.76M
25 Q2104.02M
25 Q1131.65M
24 Q4129.72M
24 Q3196.89M
24 Q2193.75M
24 Q1167.32M
Cash Flows (SEK) · TTM
-100M-50M050M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XVIPY Cash Flows (SEK) · TTM by quarter
PeriodCash Flows (SEK) · TTM
26 Q20
26 Q1-27.3M
25 Q4-60.75M
25 Q3-20.9M
25 Q21.98M
25 Q134.32M
24 Q451.36M
24 Q310.32M
24 Q25.78M
24 Q19.59M
EPS (SEK) · TTM
00.511.5224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XVIPY EPS (SEK) · TTM by quarter
PeriodEPS (SEK) · TTM
26 Q20.71
26 Q10.6
25 Q40.2
25 Q30.24
25 Q20.89
25 Q11.09
24 Q41.37
24 Q31.62
24 Q20.96
24 Q10.8
Expenses (SEK) · TTM
0200M400M600M800MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XVIPY Expenses (SEK) · TTM by quarter
PeriodExpenses (SEK) · TTM
26 Q2707.53M
26 Q1671M
25 Q4627.14M
25 Q3619.93M
25 Q2623.49M
25 Q1606.03M
24 Q4590.2M
24 Q3542.46M
24 Q2527.08M
24 Q1500.62M
Shares Outstanding (SEK) · TTM
-10M-5M05M10MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XVIPY Shares Outstanding (SEK) · TTM by quarter
PeriodShares Outstanding (SEK) · TTM
26 Q20
26 Q10
25 Q40
25 Q3-6.57M
25 Q2-6.57M
25 Q1-6.57M
24 Q4-6.57M
24 Q35.76M
24 Q25.76M
24 Q15.76M
PE Ratio
0200400600800med 133.13Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
XVIPY PE Ratio by quarter
PeriodPE Ratio
Sep 26111.95
Aug 26120.22
Aug 26131.52
Jun 26347.5
Feb 26239.99
Jan 26242.89
Dec 2548.65
Dec 2549.91
Nov 2549.63
Nov 2545.81
Nov 2550.85
Oct 2555.71
Sep 2540.08
Jul 2550.04
Jun 2565.08
Jun 2553.48
Jun 2553.71
Nov 24121.12
Nov 24120.03
Oct 24127.26
Oct 24134.73
Oct 24128.5
Oct 24130.47
Sep 24161.1
Sep 24158.2
Sep 24159.02
Aug 24166.01
Aug 24169.57
Aug 24159.99
Aug 24151.79
Jul 24170.14
May 24149.68
Apr 24109.42
Aug 23295.41
May 23471.92
Apr 23392.62
Mar 23244.77
Dec 22240.64
Nov 22222.6
Sep 22773.69
Free Cash Flow Yield
-1%-0.5%0%0.5%1%med 0.04%Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
XVIPY Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-0.33%
Aug 26-0.3%
Aug 26-0.28%
Jun 26-0.71%
Feb 26-0.29%
Jan 26-0.29%
Dec 250.04%
Dec 250.04%
Nov 250.04%
Nov 250.04%
Nov 250.03%
Oct 250.03%
Sep 250.62%
Jul 250.5%
Jun 250.38%
Jun 250.56%
Jun 250.56%
Nov 240.04%
Nov 240.04%
Oct 240.04%
Oct 240.04%
Oct 240.04%
Oct 240.04%
Sep 240.06%
Sep 240.06%
Sep 240.06%
Aug 240.06%
Aug 240.06%
Aug 240.06%
Aug 240.06%
Jul 240.06%
May 240.02%
Apr 240.03%
Aug 230%
May 230.11%
Apr 230.13%
Mar 23-0.16%
Dec 22-0.59%
Nov 22-0.63%
Sep 22-0.81%
Price to Sales
0102030med 17.28Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
XVIPY Price to Sales by quarter
PeriodPrice to Sales
Sep 269.97
Aug 2610.71
Aug 2611.72
Jun 2610.56
Feb 268.83
Jan 268.94
Dec 256.58
Dec 256.76
Nov 256.72
Nov 256.2
Nov 256.88
Oct 257.54
Sep 256.42
Jul 258.02
Jun 2510.43
Jun 2511.2
Jun 2511.24
Nov 2420.93
Nov 2420.74
Oct 2421.99
Oct 2423.28
Oct 2422.2
Oct 2422.54
Sep 2425.16
Sep 2424.71
Sep 2424.84
Aug 2425.93
Aug 2426.49
Aug 2424.99
Aug 2423.71
Jul 2426.58
May 2423
Apr 2416.81
Aug 2317.75
May 2320.94
Apr 2317.42
Mar 2319.79
Dec 2217.15
Nov 2215.86
Sep 2218.2
EV/EBITDA
255075100125150med 75.05Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
XVIPY EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2651.15
Aug 2655.02
Aug 2660.3
Jun 2657.51
Feb 2659.49
Jan 2660.23
Dec 2550.05
Dec 2551.4
Nov 2551.1
Nov 2547.01
Nov 2552.4
Oct 2557.61
Sep 2539.53
Jul 2549.9
Jun 2565.55
Jun 2568.04
Jun 2568.34
Nov 2473.14
Nov 2472.46
Oct 2476.96
Oct 2481.62
Oct 2477.73
Oct 2478.96
Sep 2493.83
Sep 2492.08
Sep 2492.58
Aug 2496.77
Aug 2498.91
Aug 2493.16
Aug 2488.24
Jul 2499.25
May 2485.34
Apr 2461.49
Aug 23112.36
May 23129.97
Apr 23107.52
Mar 23131.09
Dec 22102.65
Nov 2294.51
Sep 22139.5
Price/Operating Cashflow
050010001500med 211.03Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
XVIPY Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2646.86
Aug 2650.33
Aug 2655.06
Jun 2689.53
Feb 2695.43
Jan 2696.58
Dec 2569.01
Dec 2570.81
Nov 2570.41
Nov 2564.99
Nov 2572.14
Oct 2579.03
Sep 2558.14
Jul 2572.59
Jun 2594.41
Jun 2582.74
Jun 2583.09
Nov 24211.03
Nov 24209.13
Oct 24221.73
Oct 24234.74
Oct 24223.88
Oct 24227.31
Sep 24268.29
Sep 24263.46
Sep 24264.83
Aug 24276.46
Aug 24282.39
Aug 24266.45
Aug 24252.79
Jul 24283.34
May 24296.92
Apr 24217.07
Aug 23331.92
May 23312.18
Apr 23259.72
Mar 231328.65
Price to Book
246810med 4.8Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
XVIPY Price to Book by quarter
PeriodPrice to Book
Sep 263.87
Aug 264.15
Aug 264.54
Jun 264.02
Feb 263.43
Jan 263.47
Dec 252.59
Dec 252.66
Nov 252.64
Nov 252.44
Nov 252.71
Oct 252.97
Sep 252.62
Jul 253.28
Jun 254.26
Jun 254.27
Jun 254.29
Nov 247.22
Nov 247.16
Oct 247.59
Oct 248.03
Oct 247.66
Oct 247.78
Sep 248.08
Sep 247.93
Sep 247.97
Aug 248.32
Aug 248.5
Aug 248.02
Aug 247.61
Jul 248.53
May 247.07
Apr 245.17
Aug 235.68
May 236.08
Apr 235.06
Mar 235.29
Dec 224.18
Nov 223.86
Sep 224.1
Xvivo Perfusion AB (publ)
XVIPY
Stockpicker

Video analysis: XVIPY

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: XVIPY

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.